GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (FRA:36X) » Definitions » Dividends Paid

Ascentage Pharma Group International (FRA:36X) Dividends Paid


View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International Dividends Paid?

Dividends Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Ascentage Pharma Group International Business Description

Address
68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.